[Symptomatic treatment of painful diabetic neuropathy]

Nihon Rinsho. 2005 Jun:63 Suppl 6:609-13.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Amines / therapeutic use*
  • Anti-Asthmatic Agents / therapeutic use*
  • Anticonvulsants / therapeutic use*
  • Antidepressive Agents / therapeutic use*
  • Antitussive Agents / therapeutic use
  • Cyclohexanecarboxylic Acids / therapeutic use*
  • Dextromethorphan / therapeutic use
  • Diabetic Neuropathies / etiology
  • Diabetic Neuropathies / therapy*
  • Fructose / analogs & derivatives
  • Fructose / therapeutic use
  • Gabapentin
  • Ganglia, Spinal / physiology
  • Humans
  • Lamotrigine
  • Mexiletine / therapeutic use*
  • Nerve Fibers / physiology
  • Posterior Horn Cells / physiology
  • Pregabalin
  • Selective Serotonin Reuptake Inhibitors / therapeutic use*
  • Sodium Channels / physiology
  • Topiramate
  • Triazines / therapeutic use
  • gamma-Aminobutyric Acid / analogs & derivatives
  • gamma-Aminobutyric Acid / therapeutic use*

Substances

  • Amines
  • Anti-Asthmatic Agents
  • Anticonvulsants
  • Antidepressive Agents
  • Antitussive Agents
  • Cyclohexanecarboxylic Acids
  • Serotonin Uptake Inhibitors
  • Sodium Channels
  • Triazines
  • Topiramate
  • Mexiletine
  • Fructose
  • Pregabalin
  • gamma-Aminobutyric Acid
  • Gabapentin
  • Dextromethorphan
  • Lamotrigine